- 1101. Hepatitis B Antigen Peptide
- (UMLS (NCI) C0796320) peptide, hepatitis B antigen;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 1151. Hepatoid Adenocarcinoma
- [An adenocarcinoma with morphologic characteristics similar to hepatocellular carcinoma, arising from an anatomic site other than the liver. ( NCI )] (UMLS (NCI) C1266090) Hepatoid Carcinoma;
=Neoplastic Process |
- 1102. HEPATITIS B CARRIER
- [ ] (UMLS (ICD9CM) C0262505) =Patient or Disabled Group
| - 1152. hepatolith
- [ ] (UMLS (CSP) C0598160) =Body Substance
|
- 1103. Hepatitis B Virus Antibody
- [An antibody produced by B lymphocytes in response to hepatitis B hepadnaviral infection. ( NCI )] (UMLS (NCI) C0019164) =Immunologic Factor ;
| - 1153. Hepatology
- [The discipline of Hepatology encompasses the structure, function, and diseases of the liver and biliary tract. The American Board of Internal Medicine considers Hepatology part of the subspecialty of gastroenterology. Physicians who identify themselves as Hepatologists usually, but not always, have been trained in gastrointestinal programs. Training Programs, and/or Fellowships, Preceptorships: The American Association for the Study of Liver Diseases (AASLD) is the major professional society organized for physicians with an interest in Hepatology. A subcommittee of that organization has published guidelines for training programs in the 1992 November issue of Hepatology.Source: The American Board of Internal Medicine 9/1993ACGME Accredited Residency Program Requirements: None ( HL7V3.0 )] (UMLS (HL7) C1555763) =Professional or Occupational Group =Internal Medicine;
|
- 1104. hepatitis B virus group
- [DNA virus having complex, double-layered virions 42 nm in diameter; etiologic agent of hepatitis B; associated with the development of hepatocellular carcinomas. ( CSP )] (UMLS (CSP) C0206406) =Virus =Hepadnaviridae;
hepatitis virus | - 1154. hepatoma cell
- [ ] (UMLS (CSP) C0677626) =Cell
|
- 1105. Hepatitis B Virus Related Hepatocellular Carcinoma
- (UMLS (NCI) C1333977) Hepatitis B Virus-Related Hepatocellular Carcinoma =Neoplastic Process ;
| - 1155. Hepatomegaly
- [Abnormal enlargement of the liver.(NCI)] (UMLS (ICPC) C0019209) (Hepatomegaly; HEPATOMEGALIA; Hepatomegali; Hepatomegalie; SUURENTUNUT MAKSA; Hepatomegalie; Hepatomegalie; (108); hepatomegalia; Epatomegalia; FORSTORRET LEVER/HEPATOMEGALI - r16.0 - r16.2; Hepatomegalia; Hepatomegalia; FORSTORAD LEVER) =Sign or Symptom ;
=Body System, Gastrointestinal; hypertrophy; Diagnosis/Diseases Component; |
- 1106. Hepatitis B Virus-X
- [Hepatitis B virus X protein; a hepatitis B viral product relevant to hepatocarcinogenesis. ( NCI )] (UMLS (NCI) C0062529) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 1156. Hepatorenal syndrome
- [Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention. ( MSH )] (UMLS (ICD9CM) C0019212) =Disease or Syndrome ;
=Kidney Disease;
Hepatic Disorder |
- 1107. hepatitis C
- [viral disease caused by hepatitis C virus; most common form of post transfusion hepatitis, also is a common acute sporadic hepatitis; may also follow parental drug abuse. ( CSP )] (UMLS (NCI) C0019196) =Disease or Syndrome ;
=Hepatitis, Viral, Human;
Flaviviridae Infections;
infectious hepatitis;
=Hepatitis C, Chronic | - 1157. Hepatosplenic Gamma/Delta T-Cell Lymphoma
- [An aggressive, extranodal, and systemic mature T-cell non-Hodgkin lymphoma, derived from cytotoxic T-cells, usually of gamma/delta T-cell receptor type. Patients usually manifest marked thrombocytopenia, often associated with anemia and leukocytosis. (WHO, 2001) ( NCI )] (UMLS (NCI) C1333984) Hepatosplenic T-Cell Lymphoma =Neoplastic Process ;
|
- 1108. HEPATITIS C CARRIER
- (UMLS (ICD9CM) C0400920) =Finding ;
| - 1158. HEPATOTOMY
- (UMLS (ICD9CM) C0193377) =Therapeutic or Preventive Procedure
|
- 1109. Hepatitis C Virus Related Hepatocellular Carcinoma
- (UMLS (NCI) C1333978) Hepatitis C Virus-Related Hepatocellular Carcinoma =Neoplastic Process ;
| - 1159. hepatotoxin
- [poisonous substance that damages or destroys liver cells. ( CSP )] (UMLS (CSP) C0596691) =Hazardous or Poisonous Substance ;
=Toxin;
|
- 1110. Hepatitis delta without mention of active hepatitis B disease or hepatic coma
- [ ] (UMLS (ICD9CM) C0375011) =Disease or Syndrome
| - 1160. Hepatovirus
- [RNA virus having virions 27-29 nm in diameter and a single stranded genome; causes short incubation hepatitis (hepatitis A); usually caused by water or food + borne infection. ( CSP )] (UMLS (CSP) C0019160) =Virus ;
=Picornaviridae;
=hepatitis A virus |
- 1111. Hepatitis delta without mention of active hepatitis B disease with hepatic coma
- [ ] (UMLS (ICD9CM) C0153083) =Disease or Syndrome
| - 1161. Heporal
- (UMLS (NCI) C0809917) =Organic Chemical; Pharmacologic Substance
|
- 1112. Hepatitis due to toxoplasmosis
- (UMLS (ICD9CM) C0400895) =Disease or Syndrome ;
| - 1162. heptose
- [ ] (UMLS (CSP) C0019229) =Carbohydrate ;
|
- 1113. hepatitis E
- [Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission. ( MSH )] (UMLS (CSP) C0085293) =Disease or Syndrome =Hepatitis, Viral, Human;
Caliciviridae Infections | - 1163. HER-2-neu peptide vaccine/Montanide ISA-51
- (UMLS (NCI) C0879332) =Therapeutic or Preventive Procedure
|
- 1114. hepatitis E virus
- [positive stranded RNA virus species in an unassigned genus, Hepatitis E like Viruses, causing enterically transmitted non A, non B hepatitis (hepatitis E). ( CSP )] (UMLS (CSP) C0085294) =Virus =hepatitis virus;
RNA virus | - 1164. HER-2-Neu Peptide Vaccine/Sargramostim
- (UMLS (NCI) C0879358) =Therapeutic or Preventive Procedure ;
|
- 1115. Hepatitis E with hepatic coma
- [ ] (UMLS (ICD9CM) C0153084) =Disease or Syndrome
| - 1165. HER-2/neu Helper-Peptide Vaccine
- [A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types. (NCI04) ( NCI )] (UMLS (NCI) C0879250) HER-2/neu Peptide Vaccine;
HER-2-Neu Peptide Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 1116. Hepatitis E without mention of hepatic coma
- [ ] (UMLS (ICD9CM) C0153088) =Disease or Syndrome
| - 1166. herbal medicine
- [The study of medicines derived from botanical sources. ( MSH )] (UMLS (CSP) C1533719) =Biomedical Occupation or Discipline; ;
|
- 1117. hepatitis F virus
- [ ] (UMLS (CSP) C1328895) =Virus ;
| - 1167. herbal tea
- [ ] (UMLS (CSP) C0019233) =Food ;
|
- 1118. HEPATITIS IN OTH INF DIS
- [ ] (UMLS (ICD9CM) C0156197) =Disease or Syndrome
| - 1168. herbicide
- [agent used to destroy unwanted vegetation. ( CSP )] (UMLS (NCI) C0019236) =Hazardous or Poisonous Substance ;
=pesticide;
=paraquat;
2,4,D/2,4,5,T;
|
- 1119. HEPATITIS IN VIRAL DIS
- [ ] (UMLS (ICD9CM) C0156196) =Disease or Syndrome
| - 1169. HERED CHOROID ATROPH NOS
- [ ] (UMLS (ICD9CM) C0154893) =Disease or Syndrome
|
- 1120. hepatitis nonA nonB virus
- [ ] (UMLS (CSP) C0700073) =Virus ;
| - 1170. HERED HEMOLYTIC ANEM NEC
- [ ] (UMLS (ICD9CM) C0154296) =Disease or Syndrome
|
- 1121. hepatitis vaccine
- [vaccine raised against any virus or viral derivative that causes hepatitis. ( CSP )] (UMLS (CSP) C0042723) =Pharmacologic Substance; Immunologic Factor =viral vaccine;
| - 1171. HERED PERIPH NEUROPATHY
- [ ] (UMLS (ICD9CM) C0392553) =Disease or Syndrome ;
|
- 1122. hepatitis virus
- [any of the viruses that cause inflammation of the liver; includes both DNA and RNA viruses as well viruses from humans and animals; prefer specific RT and NTs whenever possible. ( CSP )] (UMLS (CSP) C0019186) =Virus ;
=virus characteristic;
=delta agent;
hepatitis E virus;
hepatitis B virus group;
HCV;
hepatitis A virus;
GB virus C;
| - 1172. HERED PROG MUSC DYSTRPHY
- [general term for a group of inherited disorders which are characterized by progressive degeneration of skeletal muscles. ( CSP )] (UMLS (ICD9CM) C0026850) =Congenital Abnormality; Disease or Syndrome =Genetic Condition;
muscle disorder;
Heredodegenerative Disorders, Nervous System;
Muscular Disorders, Atrophic =Duchenne muscular dystrophy;
myotonia atrophica;
Duchenne muscular dystrophy;
myotonia atrophica;
facioscapulohumeral muscular dystrophy;
Muscular Dystrophy, Emery-Dreifuss |
- 1123. hepatitis virus (nonhuman)
- [ ] (UMLS (CSP) C1328896) =Virus
| - 1173. HERED RETIN DYSTRPHY NOS
- [ ] (UMLS (ICD9CM) C0154860) =Disease or Syndrome
|
- 1124. Hepatitis Virus Related Hepatocellular Carcinoma
- (UMLS (NCI) C1333979) Hepatitis Virus-Related Hepatocellular Carcinoma =Neoplastic Process ;
| - 1174. HERED SENSORY NEUROPATHY
- [group of peripheral nervous system hereditary disorders with varying course, symptoms, neuropathology, and genetics, but characterized by degeneration of peripheral nerves, and clinically by loss of sensation. ( CSP )] (UMLS (ICD9CM) C0699739) =Disease or Syndrome =Peripheral Sensory Neuropathy;
hereditary peripheral nervous system disorder |
- 1125. Hepato-Biliary Precancerous Condition
- (UMLS (NCI) C1333980) Hepato-Biliary Premalignant Condition =Disease or Syndrome ;
| - 1175. HERED SPASTIC PARAPLEGIA
- [A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8) ( MSH )] (UMLS (ICD9CM) C0037773) =Disease or Syndrome ;
=Hereditary Motor and Sensory Neuropathies;
|
- 1126. HEPATOBILIARY DISORDERS
- [Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI) ( NCI )] (UMLS (NCI) C0267792) =Disease or Syndrome ;
| - 1176. HEREDIT HEMORR TELANGIEC
- [An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA. ( MSH )] (UMLS (ICD9CM) C0039445) =Disease or Syndrome ;
=telangiectasia;
Vascular Hemostatic Disorders |
- 1127. Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation
- [A hepatoblastoma composed of cells resembling fetal epithelial cells and small round cells resembling blastema cells. ( NCI )] (UMLS (NCI) C1333981) =Neoplastic Process ;
| - 1177. HEREDIT TOOTH STRUCT NEC
- [ ] (UMLS (ICD9CM) C0868848) Hereditary disturbances in tooth structure, not elsewhere classified =Congenital Abnormality
|
- 1128. Hepatoblastoma with Pure Fetal Epithelial Differentiation
- [A hepatoblastoma composed of small cells resembling the fetal hepatocytes, forming thin trabeculae. ( NCI )] (UMLS (NCI) C1333982) =Neoplastic Process ;
| - 1178. hereditary
- [(ha-RED-ih-tair-ee) Transmitted from parent to child by information contained in the genes. ( NCI )] (UMLS (NCI) C0439660) =Functional Concept
|
- 1129. Hepatoblastoma, Nonresectable
- [Hepatoblastoma not amenable to surgical removal. ( NCI )] (UMLS (NCI) C0854796) Non-Resectable Hepatoblastoma;
Unresectable Hepatoblastoma =Neoplastic Process | - 1179. HEREDITARY AND DEGENERATIVE DISEASES OF THE CENTRAL NERVOUS SYSTEM
- (UMLS (ICD9CM) C1444208) =Disease or Syndrome ;
|
- 1130. Hepatoblastoma, Recurrent
- [The reemergence of hepatoblastoma after a period of remission. ( NCI )] (UMLS (NCI) C0854798) Recurrent Hepatoblastoma;
Relapsed Hepatoblastoma =Neoplastic Process | - 1180. Hereditary and idiopathic peripheral neuropathy
- [ ] (UMLS (ICD9CM) C0154754) =Disease or Syndrome
|
- 1131. Hepatoblastoma, Resectable
- [Hepatoblastoma amenable to surgical removal. ( NCI )] (UMLS (NCI) C0854797) Resectable Hepatoblastoma;
=Neoplastic Process | - 1181. hereditary ataxia
- [ ] (UMLS (CSP) C0004138) =Disease or Syndrome
|
- 1132. Hepatocellular Cancer Stage I
- (UMLS (NCI) C1336456) Liver Cell Cancer Stage I;
Stage I Hepatocellular Cancer;
Stage I Hepatocellular Carcinoma;
Stage I Liver Cell Cancer;
Stage I Liver Cell Carcinoma;
=Neoplastic Process | - 1182. Hereditary Benign Intraepithelial Dyskeratosis
- (UMLS (NCI) C0265966) =Disease or Syndrome ;
|
- 1133. Hepatocellular Cancer Stage III
- (UMLS (NCI) C1336248) Liver Cell Cancer Stage III;
Stage III Carcinoma of Liver Cells;
Stage III Carcinoma of the Liver Cells;
Stage III Hepatocellular Cancer;
Stage III Hepatocellular Carcinoma;
Stage III Liver Cell Cancer =Neoplastic Process | - 1183. hereditary carnitine deficiency lipid storage myopathy
- [ ] (UMLS (CSP) C0598584) =Disease or Syndrome
|
- 1134. Hepatocellular Cancer Stage IV
- (UMLS (NCI) C1336418) Liver Cell Cancer Stage IV;
Stage IV Hepatocellular Cancer;
Stage IV Hepatocellular Carcinoma;
Stage IV Liver Cell Cancer;
Stage IV Liver Cell Carcinoma =Neoplastic Process | - 1184. hereditary carnitine deficiency myopathy
- [rare genetic carnitine metabolic disorder that causes extreme muscle weakness; carnitine functions in the body as a carrier of fatty acids to the energy centers in muscles (mitochondria). ( CSP )] (UMLS (CSP) C0596692) =Disease or Syndrome ;
=inborn biological transport disorder;
|
- 1135. hepatocellular cancer, screening for
- (UMLS (NCI) C0796544) liver cancer, screening for;
Screening for Hepatocellular Cancer;
screening for liver cancer =Therapeutic or Preventive Procedure | - 1185. hereditary cerebellar degeneration
- [ ] (UMLS (CSP) C0270752) =Disease or Syndrome
|
- 1136. Hepatocellular Carcinoma Protein HHCM
- [Encoded by human HHCM Gene, 467-amino acid 52-kD Hepatocellular Carcinoma Protein HHCM exhibits transforming ability on fibroblasts and liver cells. (from LocusLink, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C1333983) HHC(M);
HHCM;
HHCM Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1186. hereditary ceroid lipofuscinosis
- [inherited degenerative disease characterized by neuronal cytoplasmic inclusions which stain positively for ceroid and lipofuscin. ( CSP )] (UMLS (CSP) C0027877) =Disease or Syndrome ;
=inborn lipid storage disorder;
Arrieration mentale;
Heredodegenerative Disorders, Nervous System;
|
- 1137. Hepatocellular Carcinoma, Recurrent
- [The reemergence of hepatic neoplasm malignant after a period of remission ( NCI )] (UMLS (NCI) C0861876) Recurrent Carcinoma of Liver Cell;
Recurrent Carcinoma of the Liver Cell;
Recurrent Hepatocellular Carcinoma;
Recurrent Hepatoma;
Recurrent Liver Cell Carcinoma;
Relapsed Carcinoma of Liver Cell;
Relapsed Carcinoma of the Liver Cell;
Relapsed Hepatocellular Carcinoma;
Relapsed Hepatoma;
Relapsed Liver Cell Carcinoma =Neoplastic Process | - 1187. hereditary chorea
- [ ] (UMLS (CSP) C0699731) =Disease or Syndrome
|
- 1138. Hepatocellular Carcinoma, Resectable
- (UMLS (NCI) C0863194) Resectable Carcinoma of Liver Cell;
Resectable Carcinoma of the Liver Cell;
Resectable Hepatocellular Carcinoma;
Resectable Hepatoma;
Resectable Liver Cell Carcinoma =Neoplastic Process | - 1188. Hereditary Clear Cell Renal Cell Carcinoma
- [A manifestation of von Hippel-Lindau disease or other familial renal cell cancer syndromes that present as a malignant epithelial neoplasm of the kidney. It is characterized by the presence of lipid-containing clear cells within a vascular network. The tumor usually is bilateral and polycentric, and metastasizes to unusual sites. Late metastasis is common. ( NCI )] (UMLS (NCI) C1333985) Hereditary Conventional (Clear Cell) Renal Cell Carcinoma =Neoplastic Process ;
|
- 1139. Hepatocellular Damage
- (UMLS (NCI) C0151763) =Pathologic Function
| - 1189. hereditary coproporphyria porphyria
- [An autosomal dominant porphyria that is due to a deficiency of COPROPORPHYRINOGEN OXIDASE in the LIVER, the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, 5-AMINOLEVULINATE and COPROPORPHYRINS. ( MSH )] (UMLS (CSP) C0162531) =Disease or Syndrome
|
- 1140. Hepatocullular Cancer Stage II
- (UMLS (NCI) C1336290) Liver Cell Cancer Stage II;
Stage II Hepatocellular Cancer;
Stage II Hepatocellular Carcinoma;
Stage II Liver Cell Cancer;
Stage II Liver Cell Carcinoma;
=Neoplastic Process | - 1190. Hereditary disease in family possibly affecting fetus, affecting management of mother
- [ ] (UMLS (ICD9CM) C0157072) =Disease or Syndrome ;
|
- 1141. hepatocyte
- [(HEP-a-toe-site) A liver cell. ( NCI )] (UMLS (NCI) C0227525) =Cell = ;
Body System, Hepatic =Kupffer Cell | - 1191. HEREDITARY EDEMA OF LEGS
- [ ] (UMLS (ICD9CM) C1313885) =Disease or Syndrome; ;
|
- 1142. hepatocyte growth factor
- [newly identified and characterized growth factor; involved in regulating cell migration. ( CSP )] (UMLS (CSP) C0062534) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Growth Agents;
Cytokine | - 1192. hereditary factor VII deficiency
- [ ] (UMLS (CSP) C0272320) =Disease or Syndrome
|
- 1143. Hepatocyte Growth Factor Receptor Signaling Pathway
- [The hepatocyte growth factor receptor, also called c-Met, is activated by HGF and stimulates proliferation of hepatocytes and other cell types. Mutated forms of the HGF receptor are associated with oncogenesis and metastasis, making the HGF receptor a potential therapeutic target for cancer drugs. Changes in cell motility, cell shape, adhesion, resistance to apoptosis, and anchorage independent growth all contribute to the role of c-Met in cancer. The HGF receptor is a heterodimer with tyrosine kinase activity and associates with a multiprotein complex involved in downstream signal transduction. The HGF receptor can associate More…
| - 1193. hereditary hemochromatosis
- [disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary; full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron; an autosomal recessive disorder of metabolism associated with a gene tightly linked to the A locus of the HLA complex on chromosome 6. ( CSP )] (UMLS (CSP) C0392514) =Disease or Syndrome ;
=inborn metal metabolism disorder;
|
- 1144. Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate
- [HGS is a downstream signaling molecule. It undergoes tyrosine phosphorylation in response to IL2, CSF2, or HGF. ( NCI )] (UMLS (NCI) C0382631) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1194. Hereditary hemolytic anemias
- [includes hereditary erythrocyte membrane defects, enzyme deficiencies, hemoglobin abnormalities, stem cell defects (paroxysmal nocturnal hemoglobinuria), and alloimmune (Rh) disease of newborn.(CSP)] (UMLS (ICPC) C0002881) (Hereditary hemolytic anemias; ANEMIA HEMOLITIKOA; Medfodt haemolytisk anaemi; Erfelijke hemolytische anemie; PERINNOLLISET HEMOLYYTTISET ANEMIAT; Anemies hemolytiques hereditaires; Hereditaere Haemolytische Anaemie; (108); orokletes haemolytikus anaemiak; Anemie emolitiche ereditarie; MEDFODTE HEMOLYTISKE ANEMIER; Anemias hemoliticas hereditarias; Anemias hemoliticas hereditarias; ARFTLIGA HEMOLYTISKA ANEMIER) =Disease or Syndrome
|
- 1145. Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate Gene
- [This gene plays a role in signal transduction and regulation of intracellular protein transport. ( NCI )] (UMLS (NCI) C1366514) HGS;
HGS Gene =Gene or Genome | - 1195. hereditary hyperbilirubinemia
- [inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood. ( CSP )] (UMLS (CSP) C0020435) =Disease or Syndrome =hyperbilirubinemia;
Congenital Metabolic Disorder;
Congenital anomalies of the integument;
=Crigler Najjar syndrome;
congenital nonhemolytic jaundice |
- 1146. Hepatocyte Nitric Oxide Synthase
- [Induced by lipopolysaccharide, endotoxins, and cytokines and expressed as 2 alternative isoforms in liver, retina, bone cells, and airway epithelia by human NOS2A Gene (NOS Family), calcium/calmodulin stimulated homodimeric Nitric Oxide Synthase 2A binds FAD and FMN cofactors, contains a flavodoxin-like domain, requires BH4 which may stabilize the dimer, and synthesizes reactive free radical nitric oxide messenger (from L-arginine). NO has antimicrobial and antitumoral activities in macrophages. NOS2A binds SLC9A3R1. IL12 requires NOS2 to stimulate NK cell cytotoxicity and to activate STAT4 tyrosine-phosphorylation by TYK2 in innate immunity. Aspirin inhibits NOS2A. (NCI) ( NCI )] (UMLS (NCI) C0669372) =Amino Acid, Peptide, or Protein; Enzyme
| - 1196. hereditary hyperglycemic obesity
- [inherited abnormal increase of glucose in the blood resulting in an increase in body weight beyond skeletal and physical standards as the result of an excessive accumulation of fat in the body. ( CSP )] (UMLS (CSP) C0596693) =Pathologic Function ;
=Carbohydrate Metabolism, Inborn Errors;
|
- 1147. hepatocyte nuclear factor
- [Hepatocyte nuclear factors are a family of evolutionarily conserved transcription factors that are preferentially expressed in HEPATOCYTES. They play important roles in liver-specific transcription and are critical for CELL DIFFERENTIATION and METABOLISM. ( MSH )] (UMLS (CSP) C0872184) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1197. Hereditary Nephritis
- [A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE. ( MSH )] (UMLS (NCI) C0027706) =Disease or Syndrome =nephritis;
Congenital Genitourinary Abnormality |
- 1148. hepatocyte stimulating factor III
- [ ] (UMLS (CSP) C0598769) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 1198. hereditary neuropathy
- [ ] (UMLS (CSP) C0598589) =Disease or Syndrome
|
- 1149. hepatoencephalomyelitis reovirus 3
- [ ] (UMLS (CSP) C0599039) =Virus ;
| - 1199. HEREDITARY OPTIC ATROPHY
- [Hereditary conditions that feature progressive visual loss in association with optic atrophy. Relatively common forms include autosomal dominant optic atrophy (OPTIC ATROPHY, AUTOSOMAL DOMINANT) and Leber hereditary optic atrophy (OPTIC ATROPHY, HEREDITARY, LEBER). ( MSH )] (UMLS (ICD9CM) C0029125) =Congenital Abnormality; Disease or Syndrome =Eye Diseases, Hereditary;
optic atrophy;
Heredodegenerative Disorders, Nervous System;
|
- 1150. Hepatogastric Ligament
- (UMLS (NCI) C0230232) =Body Part, Organ, or Organ Component
| - 1200. hereditary peripheral nervous system disorder
- [inherited diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. ( CSP )] (UMLS (CSP) C0596694) =Disease or Syndrome ;
=Genetic Condition;
DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM =Hereditary Motor and Sensory Neuropathies;
HERED SENSORY NEUROPATHY |
home
